Advertisement

Ads Placeholder
Loading...

Cosmo Pharmaceuticals N.V.

CMOPF•PNK
Healthcare
Drug Manufacturers - General
$110.00
$1.00(0.92%)
U.S. Market opens in 16h 12m

Cosmo Pharmaceuticals N.V. (CMOPF) Stock Overview

Explore Cosmo Pharmaceuticals N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.8B
P/E Ratio-418.54
EPS (TTM)$-0.26
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$129.58
3 Months$89.69
1 Year Target$112.39

CMOPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cosmo Pharmaceuticals N.V. (CMOPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.12, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $112.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -418.54 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.92%
5-Day Change
N/A
1-Month Change
-19.66%
3-Month Change
-19.84%
6-Month Change
32.45%
Year-to-Date (YTD) Change
-20.89%
1-Year Change
75.16%
3-Year Change
80.33%
5-Year Change
23.32%
All-Time (Max) Change
-31.54%

Contact Information

https://www.cosmopharma.com
353 1 817 0370
Riverside II, Dublin, NaN, 2

Company Facts

3,210 Employees
IPO DateJul 31, 2017
CountryIE
Actively Trading

Frequently Asked Questions